Anders Fink-jensen, Md, Dmsci

This study tests whether tirzepatide, a drug approved for diabetes and obesity, can help people with both schizophrenia and alcohol use disorder drink less. About 108 participants will receive either tirzepatide or a placebo for 16 weeks, and researchers will track changes in hea…